Shares of Gilead Sciences Inc. GILD shed 1.74% to $63.82 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 1.07% to 3,924.26 and Dow Jones Industrial Average DJIA falling 1.07% to 31,318.44. The stock’s fall snapped a four-day winning streak. Gilead Sciences Inc. closed $10.30 below its 52-week high ($74.12), which the company reached on December 30th.
The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson JNJ fell 1.57% to $162.74, Merck & Co. Inc. MRK fell 1.06% to $86.23, and AbbVie Inc. ABBV fell 1.57% to $136.28. Trading volume (6.7 M) eclipsed its 50-day average volume of 6.1 M.